BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
220 hedge funds and large institutions have $4.68B invested in Blueprint Medicines in 2019 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 94 increasing their positions, 46 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
220
Holders Change
+17
Holders Change %
+8.37%
% of All Funds
4.79%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.17%
New
54
Increased
94
Reduced
46
Closed
34
Calls
$63.8M
Puts
$40.2M
Net Calls
+$23.6M
Net Calls Change
+$25.6M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
$170M |
| 2 |
BlackRock
New York
|
$388M |
| 3 |
HM
HealthCor Management
New York
|
$36.1M |
| 4 |
CCM
Cadian Capital Management
New York
|
$49.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$404M |
